To this end, further investigation into this eosinophil-IFN-γ axis is required and may suggest novel therapies targeting this response to mitigate acute respiratory distress syndrome (ARDS) and lung inflammation. The gene discussed is IFNG; the disease is acute respiratory distress syndrome.